IN2015DN03306A - - Google Patents

Info

Publication number
IN2015DN03306A
IN2015DN03306A IN3306DEN2015A IN2015DN03306A IN 2015DN03306 A IN2015DN03306 A IN 2015DN03306A IN 3306DEN2015 A IN3306DEN2015 A IN 3306DEN2015A IN 2015DN03306 A IN2015DN03306 A IN 2015DN03306A
Authority
IN
India
Prior art keywords
compositions
present
allergen
immunotherapy
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Kleij Joanna Paulina Maria Van Der
Dirk Jan Elbertus Opstelten
Original Assignee
Hal Allergy Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hal Allergy Holding B V filed Critical Hal Allergy Holding B V
Publication of IN2015DN03306A publication Critical patent/IN2015DN03306A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN3306DEN2015 2012-10-19 2012-10-19 IN2015DN03306A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/070810 WO2014060049A1 (fr) 2012-10-19 2012-10-19 Compositions pour l'immunothérapie

Publications (1)

Publication Number Publication Date
IN2015DN03306A true IN2015DN03306A (fr) 2015-10-09

Family

ID=47071270

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3306DEN2015 IN2015DN03306A (fr) 2012-10-19 2012-10-19

Country Status (14)

Country Link
US (2) US20150250870A1 (fr)
EP (1) EP2908857B1 (fr)
JP (1) JP6336458B2 (fr)
CN (1) CN104822388A (fr)
AU (1) AU2012392291B2 (fr)
CA (1) CA2888293C (fr)
DK (1) DK2908857T3 (fr)
ES (1) ES2645740T3 (fr)
HK (1) HK1212206A1 (fr)
HU (1) HUE034729T2 (fr)
IN (1) IN2015DN03306A (fr)
PL (1) PL2908857T3 (fr)
PT (1) PT2908857T (fr)
WO (1) WO2014060049A1 (fr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2594123B2 (ja) * 1987-09-12 1997-03-26 株式会社林原生物化学研究所 減感作剤
JP2838800B2 (ja) * 1989-09-02 1998-12-16 株式会社林原生物化学研究所 減感作剤
ES2284287T3 (es) * 1998-10-16 2007-11-01 Glaxosmithkline Biologicals S.A. Sistemas adyuvantes y vacunas.
US20090155351A1 (en) * 2005-10-04 2009-06-18 Alk-Abello A/S Solid Vaccine Formulation
EP1974745B1 (fr) * 2007-03-28 2011-08-31 Alk-Abelló A/S Utilisation de formule de vaccin adjuvanté contre les allergies pour administration sous-coutané
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
EP2140880B1 (fr) * 2008-07-04 2012-11-14 HAL Allergy Holding B.V. Modification d'allergènes
US20100086568A1 (en) * 2008-08-05 2010-04-08 Koppelman Stefan Johan Modification of allergens
MX2011003752A (es) * 2008-10-15 2011-06-20 Alk Abello As Producto farmaceutico para dosificacion ascendente de vacuna contra alergia.
WO2013087119A1 (fr) * 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Formulations pharmaceutiques et leur utilisation pour le traitement d'allergie aux cacahuètes

Also Published As

Publication number Publication date
EP2908857B1 (fr) 2017-08-09
AU2012392291B2 (en) 2017-12-07
CN104822388A (zh) 2015-08-05
JP2015534955A (ja) 2015-12-07
US20200289642A1 (en) 2020-09-17
CA2888293C (fr) 2018-11-06
CA2888293A1 (fr) 2014-04-24
WO2014060049A1 (fr) 2014-04-24
PT2908857T (pt) 2017-09-11
PL2908857T3 (pl) 2018-05-30
HK1212206A1 (en) 2016-06-10
HUE034729T2 (en) 2018-02-28
US20150250870A1 (en) 2015-09-10
EP2908857A1 (fr) 2015-08-26
ES2645740T3 (es) 2017-12-07
DK2908857T3 (da) 2017-11-20
AU2012392291A1 (en) 2015-05-07
JP6336458B2 (ja) 2018-06-06

Similar Documents

Publication Publication Date Title
IN2013MN01582A (fr)
UA112416C2 (uk) Антитіло до fap і способи його застосування
BR112015020516A2 (pt) composições e métodos para imunoterapia
MX2016006316A (es) Inhibidores de mtor para potenciar la respuesta inmunitaria.
EA201290876A1 (ru) Композиции индуцированных дендритных клеток и их использование
MX2015003416A (es) Metodo para mejorar las inmunoterapias especificas en el tratamiento contra el cancer.
WO2012140274A3 (fr) Composés
IN2014DN10386A (fr)
EP3725811A3 (fr) Compositions pour inhibition d'activation du complément dépendant de masp-2
WO2011113019A3 (fr) Protéines ctla4 et leurs utilisations
IN2014MN01642A (fr)
MX346500B (es) Metodos y composiciones para inmunoterapia para enfermedad neural.
TN2012000366A1 (en) Anticoagulant antidotes
IN2014DN08721A (fr)
EA201391773A1 (ru) Клетки-предшественники мезодермальной линии
MX2020008031A (es) Composiciones y metodos para reducir el contenido de alcohol en sangre.
PH12014501410A1 (en) Compositions and methods for antibodies targeting factor p
WO2012109238A3 (fr) Procédés d'augmentation des réponses immunitaires à l'aide d'agents qui se lient directement à ire-1 et activent ire-1
MX2014006337A (es) Composiciones de proteina del gen 3 de bacteriofago y sus usos como agentes de union amiloides.
MY161868A (en) Anti-bv8 antibodies and uses thereof
WO2013072901A3 (fr) Compositions et méthodes de traitement du gliome
MX2013002960A (es) Composiciones de anticuerpo y metodos de uso.
GB2459609A (en) Methods for allergen detection
TN2013000388A1 (en) Anticoagulant antidotes
MX2014004326A (es) Anticuerpos a cd1d.